Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Significant Increase in Short Interest

Aptevo Therapeutics Inc. (NASDAQ:APVO) was the target of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 60,100 shares, an increase of 155.7% from the February 13th total of 23,500 shares. Approximately 4.1% of the shares of the company are sold short. Based on an average daily volume of 190,700 shares, the short-interest ratio is presently 0.3 days.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on Aptevo Therapeutics in a report on Monday, December 9th. They set a “sell” rating for the company.

Aptevo Therapeutics Stock Performance

Shares of Aptevo Therapeutics stock opened at $2.40 on Thursday. The business has a 50 day moving average price of $3.94 and a 200 day moving average price of $178.92. Aptevo Therapeutics has a 1 year low of $2.37 and a 1 year high of $209.38.

About Aptevo Therapeutics

Aptevo Therapeutics Inc, a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. It develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.